» Articles » PMID: 34903281

Estimating Prevalence of Human Traits Among Populations from Polygenic Risk Scores

Overview
Journal Hum Genomics
Publisher Biomed Central
Specialty Genetics
Date 2021 Dec 14
PMID 34903281
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

The genetic basis of phenotypic variation across populations has not been well explained for most traits. Several factors may cause disparities, from variation in environments to divergent population genetic structure. We hypothesized that a population-level polygenic risk score (PRS) can explain phenotypic variation among geographic populations based solely on risk allele frequencies. We applied a population-specific PRS (psPRS) to 26 populations from the 1000 Genomes to four phenotypes: lactase persistence (LP), melanoma, multiple sclerosis (MS) and height. Our models assumed additive genetic architecture among the polymorphisms in the psPRSs, as is convention. Linear psPRSs explained a significant proportion of trait variance ranging from 0.32 for height in men to 0.88 for melanoma. The best models for LP and height were linear, while those for melanoma and MS were nonlinear. As not all variants in a PRS may confer similar, or even any, risk among diverse populations, we also filtered out SNPs to assess whether variance explained was improved using psPRSs with fewer SNPs. Variance explained usually improved with fewer SNPs in the psPRS and was as high as 0.99 for height in men using only 548 of the initial 4208 SNPs. That reducing SNPs improves psPRSs performance may indicate that missing heritability is partially due to complex architecture that does not mandate additivity, undiscovered variants or spurious associations in the databases. We demonstrated that PRS-based analyses can be used across diverse populations and phenotypes for population prediction and that these comparisons can identify the universal risk variants.

Citing Articles

Importance of Diversity in Precision Medicine: Generalizability of Genetic Associations Across Ancestry Groups Toward Better Identification of Disease Susceptibility Variants.

Cruz L, Cooke Bailey J, Crawford D Annu Rev Biomed Data Sci. 2023; 6:339-356.

PMID: 37196357 PMC: 10720270. DOI: 10.1146/annurev-biodatasci-122220-113250.


Genetics and precision health: the ecological fallacy and artificial intelligence solutions.

Williams S, Moore J BioData Min. 2023; 16(1):9.

PMID: 36927508 PMC: 10018838. DOI: 10.1186/s13040-023-00327-z.


Genetics, epigenetics, and transcriptomics of preterm birth.

Jain V, Monangi N, Zhang G, Muglia L Am J Reprod Immunol. 2022; 88(4):e13600.

PMID: 35818963 PMC: 9509423. DOI: 10.1111/aji.13600.

References
1.
Galarza-Munoz G, Briggs F, Evsyukova I, Schott-Lerner G, Kennedy E, Nyanhete T . Human Epistatic Interaction Controls IL7R Splicing and Increases Multiple Sclerosis Risk. Cell. 2017; 169(1):72-84.e13. PMC: 5456452. DOI: 10.1016/j.cell.2017.03.007. View

2.
Pierrot-Deseilligny C, Souberbielle J . Vitamin D and multiple sclerosis: An update. Mult Scler Relat Disord. 2017; 14:35-45. DOI: 10.1016/j.msard.2017.03.014. View

3.
Roberts M, Asgari M, Toland A . Genome-wide association studies and polygenic risk scores for skin cancer: clinically useful yet?. Br J Dermatol. 2019; 181(6):1146-1155. PMC: 6761051. DOI: 10.1111/bjd.17917. View

4.
Prive F, Arbel J, Vilhjalmsson B . LDpred2: better, faster, stronger. Bioinformatics. 2020; 36(22-23):5424-5431. PMC: 8016455. DOI: 10.1093/bioinformatics/btaa1029. View

5.
Liu Y, Guo Y, Xiao P, Xiong D, Zhao L, Shen H . Epistasis between loci on chromosomes 2 and 6 influences human height. J Clin Endocrinol Metab. 2006; 91(10):3821-5. DOI: 10.1210/jc.2006-0348. View